Pharmacokinetics and pharmacodynamics of cannabinoids.
Grotenhermen F.
Clin Pharmacokinet. 2003;42(4):327-60. doi: 10.2165/00003088-200342040-00003.
Cannabis: A Toxin-Producing Plant with Potential Therapeutic Uses.
Breijyeh Z, Jubeh B, Bufo SA, Karaman R, Scrano L.
Toxins (Basel). 2021 Feb 5;13(2):117. doi: 10.3390/toxins13020117.
[Addictions].
Karila L, Benyamina A.
Rev Mal Respir. 2019 Feb;36(2):233-240. doi: 10.1016/j.rmr.2018.12.001. Epub 2019 Jan 24.
Cannabinoids for Substance Use Disorder Treatment: What Does the Current Evidence Say?
Fernandes JAB, Filev R, Fidalgo TM.
Cannabis Cannabinoid Res. 2023 Oct;8(5):703-715. doi: 10.1089/can.2023.0065. Epub 2023 Jun 1.
Synthetic Cannabinoids.
Mills B, Yepes A, Nugent K.
Am J Med Sci. 2015 Jul;350(1):59-62. doi: 10.1097/MAJ.0000000000000466.
Cannabinoids: emerging evidence in use and abuse.
Williams MV.
Emerg Med Pract. 2018 Aug;20(8):1-20. Epub 2018 Aug 1.
Cannabidiol and addiction.
Briânis RC, Moreira FA, Iglesias LP.
Int Rev Neurobiol. 2024;177:319-333. doi: 10.1016/bs.irn.2024.03.006. Epub 2024 Jul 3.
Evidence from Human Studies for Utilising Cannabinoids for the Treatment of Substance-Use Disorders: A Scoping Review with a Systematic Approach.
Gharbi KA, Bonomo YA, Hallinan CM.
Int J Environ Res Public Health. 2023 Feb 24;20(5):4087. doi: 10.3390/ijerph20054087.
Clinical issues in cannabis use.
Bonomo Y, Souza JDS, Jackson A, Crippa JAS, Solowij N.
Br J Clin Pharmacol. 2018 Nov;84(11):2495-2498. doi: 10.1111/bcp.13703. Epub 2018 Aug 17.
Points & Pearls: Cannabinoids: emerging evidence in use and abuse.
Williams MV, Gupta N, Nusbaum J.
Emerg Med Pract. 2018 Aug 1;20(Suppl 8):1-2.
